Business
Valneva Reports Positive Three-Year Antibody Persistence Data For Its Single-Shot Chikungunya Vaccine IXCHIQ®
(MENAFN - GlobeNewsWire - Nasdaq) Antibody levels remained high at 96% seroresponse in line with the two-year persistence data This long-lasting antibody persistence was comparable in older ...
By: menafn
- Dec 03 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS